Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2001-04-24 | Max Link (60) first became a director of CytRx in 1996. Dr. Link has been retired from business since 1994. ... Dr. Link also serves as a director of Access Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., Cell Therapeutics, Inc., Discovery Laboratories, Inc., Human Genome Sciences, Inc. and Protein Design Laboratories, Inc. |
| 2003-09-17 | Max Link (63) has been a director since 1996. Dr. Link has been retired from business since 1994. From May 1993 to June 1994, Dr. Link served as the Chief Executive Officer of Corange U.S. Holdings, Inc., the holding company for Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy International. |
| 2004-06-30 | Max Link (63) has been a director since 1996. He serves on the Audit and Nomination and Governance Committees. |
| 2005-06-07 | Max Link (64) has been a director since 1996. ... The following table provides information concerning the current membership of our Board committees: ... Max Link (III) (2) (4) ... (2) These directors constitute the members of our Audit Committee. ... (4) These directors constitute the members of our Nomination and Governance Committee. |
| 2006-06-12 | Max Link (65) has been a director since 1996, and is the Chairman of our Board of Directors. ... Our non-employee directors receive a quarterly retainer of $2,000 ($8,000 for the Chairman of the Board), a fee of $2,000 for each Board meeting attended ... Non-employee directors who serve as the Chairman of a Board committee receive an additional $2,000 for each meeting attended of the Audit Committee. |
| 2007-05-24 | Max Link (66) has been a director since 1996. Dr. Link has been retired from business since 2003. From March 2002 until its acquisition by Zimmer Holdings, Dr. Link served as Chairman and CEO of Centerpulse, Ltd. From May 1993 to June 1994, Dr. Link served as the Chief Executive Officer of Corange Ltd. (the holding company for Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy International). From 1992 to 1993, Dr. Link was Chairman of Sandoz Pharma, Ltd. From 1987 to 1992, Dr. Link was the Chief Executive Officer of Sandoz Pharma and a member of the Executive Board of Sandoz, Ltd., Basel. Prior to 1987, Dr. Link served in various capacities with the United States operations of Sandoz, including President and Chief Executive Officer. Dr. Link also serves as a director of Access Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., Celsion Corporation, Discovery Laboratories, Inc. and Human Genome Sciences, Inc., each of which is a public company. |
| 2008-05-23 | Max Link (67) has been a director since 1996. Dr. Link has been retired from business since 2003. ... Director Compensation Table shows total compensation of $178,173 in 2007. |
Data sourced from SEC filings. Last updated: 2025-12-06